What is a clinical trial?

A clinical trial is a research study involving human participants designed to evaluate medical interventions — such as drugs, devices, or behavioral strategies. Trials follow a structured protocol and are registered on ClinicalTrials.gov. They progress through phases: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale comparison), and Phase 4 (post-market surveillance).

How do I find clinical trials I'm eligible for?

You can search ClinicalTrials.gov or use ClinicalMetric to filter by condition, phase, or location. Each trial listing includes eligibility criteria such as age range, sex, diagnosis, and prior treatment history. Contact the study team directly or ask your physician to refer you to a relevant trial.

Are clinical trials safe to participate in?

Clinical trials are conducted under strict ethical and regulatory oversight, including IRB approval and FDA regulation in the US. All participants must give informed consent after reviewing potential risks and benefits. Phase 1 trials carry more uncertainty, while Phase 3 trials involve interventions with an established safety profile. Participation is always voluntary and you may withdraw at any time.

What are the phases of clinical trials?

Clinical trials progress through four main phases. Phase 1 tests safety and dosing in a small group (20–80 people). Phase 2 evaluates efficacy and side effects in a larger group (100–300). Phase 3 compares the intervention against standard treatments in thousands of participants. Phase 4 occurs after approval and monitors long-term effects in the general population.

Do participants get paid for joining clinical trials?

Many clinical trials offer compensation for time and travel expenses, though payment structures vary widely by study. Compensation is not intended to be coercive. Some trials also cover treatment costs for participants. Always review the consent form carefully and ask the study coordinator about any financial considerations before enrolling.

Phase 1 vs Phase 3 Clinical Trials: What the Difference Means for You

Medical Notice

This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.

Why Phase Matters

The phase of a clinical trial tells you where a treatment is in its development journey. A Phase 1 trial is testing a treatment for the first time in humans — very little is known about its effects. A Phase 3 trial has already passed two rounds of testing and is comparing the treatment against the current standard of care. The phase directly affects your risk profile as a participant and the likelihood that the treatment will actually help you.

Phase 1: First-in-Human Studies

Primary goal: Safety and dosing — determine the maximum tolerated dose and identify side effects.
Participants: 20–80 people, often healthy volunteers for non-oncology trials. Cancer Phase 1 trials typically enroll patients who have exhausted other options.
Risk level: Highest. The treatment has only been tested in laboratory or animal studies.
Benefit to you: Low probability of direct therapeutic benefit. Primary value is contributing to science and possibly accessing a treatment unavailable elsewhere.
Duration: Typically 6–12 months, with escalating dose cohorts.

Phase 2: Efficacy Exploration

Primary goal: Does it work? Evaluate therapeutic effect in the target patient population at the dose established in Phase 1.
Participants: 100–300 patients with the condition being studied.
Risk level: Moderate. Safety profile is partially established, but efficacy is still uncertain.
Benefit to you: Moderate. Some patients respond; others don't. Response rates are often 20–50% depending on the indication.
Duration: 1–2 years.

Phase 3: The Pivotal Trial

Primary goal: Compare against existing standard of care. Confirm efficacy and safety in a large, diverse population.
Participants: 1,000–30,000+ patients across multiple sites, often internationally.
Risk level: Lower. Extensive safety data exists. The treatment has already demonstrated efficacy in Phase 2.
Benefit to you: Higher. You have a significant probability of receiving an effective treatment, even if randomized to the control arm (which typically receives the current standard of care, not placebo).
Duration: 2–5 years.

Phase 4: Post-Approval Monitoring

Phase 4 studies occur after the FDA has approved the treatment. Goals include detecting rare side effects (that Phase 3 may have missed due to sample size), studying long-term effects, and evaluating effectiveness in special populations (elderly, children, people with multiple conditions). Risk is lowest — the treatment is already approved and in clinical use.

Which Phase Is Right for You?

For most patients, Phase 2 and Phase 3 trials offer the best balance of access to innovative treatments and established safety data. Phase 1 trials may be worth considering when:

Standard treatments have failed or are no longer effective.
No other treatment options remain.
The preclinical data for the experimental treatment is exceptionally promising.
You are comfortable with higher uncertainty in exchange for potential access.

End of Guide // ClinicalMetric Intelligence — CM-INS-003